US Bancorp DE Sells 1,379 Shares of National Research Corporation (NASDAQ:NRC)

US Bancorp DE reduced its position in National Research Corporation (NASDAQ:NRC) by 3.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 37,198 shares of the company’s stock after selling 1,379 shares during the quarter. US Bancorp DE owned 0.16% of National Research worth $476,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC grew its stake in National Research by 376.6% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,507 shares of the company’s stock worth $44,000 after acquiring an additional 1,981 shares in the last quarter. Significant Wealth Partners LLC bought a new position in National Research in the 1st quarter worth about $131,000. M&T Bank Corp bought a new position in National Research in the 1st quarter worth about $164,000. Jane Street Group LLC grew its stake in National Research by 8.6% in the 4th quarter. Jane Street Group LLC now owns 10,605 shares of the company’s stock worth $187,000 after acquiring an additional 840 shares in the last quarter. Finally, XTX Topco Ltd purchased a new stake in shares of National Research in the 4th quarter worth approximately $190,000. 47.26% of the stock is owned by hedge funds and other institutional investors.

National Research Price Performance

Shares of NRC opened at $15.53 on Wednesday. The company has a 50 day moving average price of $15.40 and a 200-day moving average price of $14.48. National Research Corporation has a fifty-two week low of $9.76 and a fifty-two week high of $22.99. The stock has a market capitalization of $353.77 million, a PE ratio of 20.43 and a beta of 0.44. The company has a debt-to-equity ratio of 3.61, a quick ratio of 0.54 and a current ratio of 0.70.

National Research (NASDAQ:NRC) last posted its earnings results on Monday, July 28th. The company reported $0.28 EPS for the quarter. National Research had a net margin of 12.78% and a return on equity of 83.52%. The company had revenue of $34.04 million during the quarter.

National Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be paid a $0.12 dividend. The ex-dividend date is Friday, September 26th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.1%. National Research’s dividend payout ratio is presently 63.16%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.